UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

Nature medicine, 2004-11, Vol.10 (11), p.1240-1244

2004

Volltextzugriff (PDF)

Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System

American journal of respiratory and critical care medicine, 2008-06, Vol.177 (11), p.1248-1254

2008

Volltextzugriff (PDF)

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4⁺ memory T lymphocyte populations

European journal of immunology, 2007-11, Vol.37 (11), p.3089-3100

2007

Volltextzugriff (PDF)

A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment

Journal of medical microbiology, 2019-12, Vol.68 (12), p.1766-1770

2019

Volltextzugriff (PDF)

Late respiratory effects of cancer treatment

Current opinion in supportive & palliative care, 2017-09, Vol.11 (3), p.197-204

2017

Volltextzugriff (PDF)

Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience

Journal of medical microbiology, 2022-07, Vol.71 (7)

2022

Volltextzugriff (PDF)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A

PloS one, 2011-08, Vol.6 (8), p.e23463-e23463

2011

Volltextzugriff (PDF)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A

PloS one, 2009-06, Vol.4 (6), p.e5934-e5934

2009

Volltextzugriff (PDF)

Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A

BMC infectious diseases, 2014-12, Vol.14 (1), p.660-660, Article 660

2014

Volltextzugriff (PDF)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

Vaccine, 2012-08, Vol.30 (38), p.5616-5624

2012

Volltextzugriff (PDF)

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis-infected Individuals

American journal of respiratory and critical care medicine, 2009-04, Vol.179 (8), p.724-733

2009

Volltextzugriff (PDF)

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials

PloS one, 2007-10, Vol.2 (10), p.e1052-e1052

2007

Volltextzugriff (PDF)

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly⁺ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis

Infection and Immunity, 2009-02, Vol.77 (2), p.622-631

2009

Volltextzugriff (PDF)

Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease

The journal of allergy and clinical immunology. Global, 2023-11, Vol.2 (4), p.100133-100133, Article 100133

2023

Volltextzugriff (PDF)

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG-Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A

Clinical and Vaccine Immunology, 2010-07, Vol.17 (7), p.1066-1073

2010

Volltextzugriff (PDF)

Food for Thought: Dietary Intervention in a Rare Cause of Severe Ventilatory Failure

European journal of case reports in internal medicine, 2020, Vol.7 (5), p.001523-001523

2020

Volltextzugriff (PDF)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials

Tuberculosis (Edinburgh, Scotland), 2005, Vol.85 (1), p.47-52

2005

Volltextzugriff (PDF)

Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 through Breastfeeding

Journal of Virology, 2007-09, Vol.81 (17), p.9408-9418

2007

Volltextzugriff (PDF)

Advances in TB vaccinology

Current respiratory medicine reviews, 2013-01, Vol.9 (3), p.172-180

2013

Volltextzugriff (PDF)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

BMJ open, 2011-01, Vol.1 (2), p.e000223-e000223

2011

Volltextzugriff (PDF)

A comparison of IFNγ detection methods used in tuberculosis vaccine trials

Tuberculosis (Edinburgh, Scotland), 2008-11, Vol.88 (6), p.631-640

2008

Volltextzugriff (PDF)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF- beta 1

Vaccine, 2008-09, Vol.26 (41), p.5269-5275

2008

Volltextzugriff (PDF)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1

Vaccine, 2008-09, Vol.26 (41), p.5269-5275

2008

Volltextzugriff (PDF)

Correction: Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations

European journal of immunology, 2011-05, Vol.41 (5), p.1501-1501

2011

Volltextzugriff (PDF)

ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adults

The European respiratory journal, 2024-03, Vol.63 (3), p.2301727

2024

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(101)

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(49)
Humans
(39)
Female
(22)
Adult
(20)
Middle Aged
(17)
Immunology
(16)
Tuberculosis
(15)
Male
(14)
Infectious Diseases
(12)
Mycobacterium Tuberculosis
(12)
General & Internal Medicine
(11)
Microbiology
(10)
Young Adult
(10)
Mycobacterium Tuberculosis - Immunology
(9)
Tuberculosis Vaccines - Immunology
(9)
Vaccines
(9)
Adolescent
(8)
Antigens
(8)
Biological And Medical Sciences
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4⁺ memory T lymphocyte populations

A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment

Late respiratory effects of cancer treatment

Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A

Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis-infected Individuals

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant ΔureC hly⁺ Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis

Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG-Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A

Food for Thought: Dietary Intervention in a Rare Cause of Severe Ventilatory Failure

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials

Vaccine Platform for Prevention of Tuberculosis and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1 through Breastfeeding

Advances in TB vaccinology

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

A comparison of IFNγ detection methods used in tuberculosis vaccine trials

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF- beta 1

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1

Correction: Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations

ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- versus -host disease in adults

Suchergebnisse filtern